Skip to main content
Erschienen in: Journal of Neurology 7/2013

01.07.2013 | Original Communication

Nocturnal hypertension and dysautonomia in patients with Parkinson’s disease: are they related?

verfasst von: Koldo Berganzo, Begoña Díez-Arrola, Beatriz Tijero, Johanne Somme, Elena Lezcano, Verónica Llorens, Iratxe Ugarriza, Roberto Ciordia, J. C. Gómez-Esteban, Juan J. Zarranz

Erschienen in: Journal of Neurology | Ausgabe 7/2013

Einloggen, um Zugang zu erhalten

Abstract

Orthostatic hypotension and supine hypertension frequently coexist in Parkinson’s disease (PD) patients, leading to visceral damage and increased mortality rates. The aim of this paper is to analyze the frequency and association of both conditions in a sample of outpatients with PD. A total of 111 patients, diagnosed with PD, were studied. Disease duration, treatment, cardiovascular risk factors, UPDRS I-IV and Scopa Aut scale scores were reported. Subjects underwent 24-h ambulatory blood pressure (BP) monitoring and were assessed for orthostatic hypotension. We compared our results with those published in 17,219 patients using the same protocol and the same type of device. Overall, 71.1 % had no proper circadian rhythm. This frequency was significantly higher than that of the control population (48 %). The prevalence of the nondipper or riser patterns was higher in patients with orthostatic hypotension (77.8 vs. 66.7 %). There was a correlation between nightly increases in diastolic blood pressure and changes in BP during the orthostatic test. Patients taking higher doses of treatment had less decreases in SBP (cc:−0.25; p = 0.007) and DBP (cc:−0.33; p < 0.001) at night, however there was no relation with drug type. The majority of patients with Parkinson’s disease show an altered circadian rhythm of blood pressure. Patients with a non-dipper or riser pattern on 24 h ABPM exhibited a higher prevalence of autonomic disorders (orthostatic hypotension) and received higher doses of dopaminergic treatment. A day–night variation in diastolic blood pressure was the most important marker of these findings.
Literatur
1.
Zurück zum Zitat Kaufmann H, Goldstein DS (2007) Autonomic dysfunction in Parkinson’s disease. Handb Clin Neurol 83:343–363PubMedCrossRef Kaufmann H, Goldstein DS (2007) Autonomic dysfunction in Parkinson’s disease. Handb Clin Neurol 83:343–363PubMedCrossRef
2.
Zurück zum Zitat Goldstein DS, Pechnik S, Holmes C, Eldadah B, Sharabi Y (2003) Association between supine hypertension and orthostatic hypotension in autonomic failure. Hypertension 42(2):136–142PubMedCrossRef Goldstein DS, Pechnik S, Holmes C, Eldadah B, Sharabi Y (2003) Association between supine hypertension and orthostatic hypotension in autonomic failure. Hypertension 42(2):136–142PubMedCrossRef
3.
Zurück zum Zitat Jones CD, Loehr L, Franceschini N, Rosamond WD, Chang PP, Shahar E et al (2012) Orthostatic hypotension as a risk factor for incident heart failure: the atherosclerosis risk in communities study. Hypertension 59(5):913–918PubMedCrossRef Jones CD, Loehr L, Franceschini N, Rosamond WD, Chang PP, Shahar E et al (2012) Orthostatic hypotension as a risk factor for incident heart failure: the atherosclerosis risk in communities study. Hypertension 59(5):913–918PubMedCrossRef
4.
Zurück zum Zitat Schmidt C, Berg D, Prieur S, Junghanns S, Schweitzer K, Globas C et al (2009) Loss of nocturnal blood pressure fall in various extrapyramidal syndromes. Mov Disord 24(14):2136–2142PubMedCrossRef Schmidt C, Berg D, Prieur S, Junghanns S, Schweitzer K, Globas C et al (2009) Loss of nocturnal blood pressure fall in various extrapyramidal syndromes. Mov Disord 24(14):2136–2142PubMedCrossRef
5.
Zurück zum Zitat Qiu C, Hu G, Kivipelto M, Laatikainen T, Antikainen R, Fratiglioni L et al (2011) Association of blood pressure and hypertension with the risk of Parkinson disease: the National FINRISK Study. Hypertension 57(6):1094–1100PubMedCrossRef Qiu C, Hu G, Kivipelto M, Laatikainen T, Antikainen R, Fratiglioni L et al (2011) Association of blood pressure and hypertension with the risk of Parkinson disease: the National FINRISK Study. Hypertension 57(6):1094–1100PubMedCrossRef
6.
Zurück zum Zitat Becker C, Jick SS, Meier CR (2008) Use of antihypertensives and the risk of Parkinson disease. Neurology 70(16 Pt 2):1438–1444PubMedCrossRef Becker C, Jick SS, Meier CR (2008) Use of antihypertensives and the risk of Parkinson disease. Neurology 70(16 Pt 2):1438–1444PubMedCrossRef
7.
Zurück zum Zitat Gorostidi M, Sobrino J, Segura J, Sierra C, de la Sierra A, Hernandez del Rey R et al (2007) Ambulatory blood pressure monitoring in hypertensive patients with high cardiovascular risk: a cross-sectional analysis of a 20,000-patient database in Spain. J Hypertens 25(5):977–984PubMedCrossRef Gorostidi M, Sobrino J, Segura J, Sierra C, de la Sierra A, Hernandez del Rey R et al (2007) Ambulatory blood pressure monitoring in hypertensive patients with high cardiovascular risk: a cross-sectional analysis of a 20,000-patient database in Spain. J Hypertens 25(5):977–984PubMedCrossRef
8.
Zurück zum Zitat Plaschke M, Trenkwalder P, Dahlheim H, Lechner C, Trenkwalder C (1998) Twenty-four-hour blood pressure profile and blood pressure responses to head-up tilt tests in Parkinson’s disease and multiple system atrophy. J Hypertens 16(10):1433–1441PubMedCrossRef Plaschke M, Trenkwalder P, Dahlheim H, Lechner C, Trenkwalder C (1998) Twenty-four-hour blood pressure profile and blood pressure responses to head-up tilt tests in Parkinson’s disease and multiple system atrophy. J Hypertens 16(10):1433–1441PubMedCrossRef
9.
Zurück zum Zitat Kurata T, Kametaka S, Ohta Y, Morimoto N, Deguchi S, Deguchi K et al (2011) PSP as distinguished from CBD, MSA-P and PD by clinical and imaging differences at an early stage. Intern Med 50(22):2775–2781PubMedCrossRef Kurata T, Kametaka S, Ohta Y, Morimoto N, Deguchi S, Deguchi K et al (2011) PSP as distinguished from CBD, MSA-P and PD by clinical and imaging differences at an early stage. Intern Med 50(22):2775–2781PubMedCrossRef
10.
Zurück zum Zitat Wilcox CS, Aminoff MJ, Slater JD (1977) Sodium homeostasis in patients with autonomic failure. Clin Sci Mol Med 53(4):321–328PubMed Wilcox CS, Aminoff MJ, Slater JD (1977) Sodium homeostasis in patients with autonomic failure. Clin Sci Mol Med 53(4):321–328PubMed
11.
Zurück zum Zitat Parati G, Pomidossi G, Albini F, Malaspina D, Mancia G (1987) Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension. J Hypertens 5(1):93–98PubMedCrossRef Parati G, Pomidossi G, Albini F, Malaspina D, Mancia G (1987) Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension. J Hypertens 5(1):93–98PubMedCrossRef
12.
Zurück zum Zitat Sommer S, Aral-Becher B, Jost W (2011) Nondipping in Parkinson’s disease. Parkinson’s disease 2011:897586PubMed Sommer S, Aral-Becher B, Jost W (2011) Nondipping in Parkinson’s disease. Parkinson’s disease 2011:897586PubMed
13.
Zurück zum Zitat Maule S, Papotti G, Naso D, Magnino C, Testa E, Veglio F (2007) Orthostatic hypotension: evaluation and treatment. Cardiovasc Hematol Disord Drug Targets 7(1):63–70PubMedCrossRef Maule S, Papotti G, Naso D, Magnino C, Testa E, Veglio F (2007) Orthostatic hypotension: evaluation and treatment. Cardiovasc Hematol Disord Drug Targets 7(1):63–70PubMedCrossRef
14.
Zurück zum Zitat Velseboer DC, de Haan RJ, Wieling W, Goldstein DS, de Bie RM (2011) Prevalence of orthostatic hypotension in Parkinson’s disease: a systematic review and meta-analysis. Parkinsonism Relat Disord 17(10):724–729PubMedCrossRef Velseboer DC, de Haan RJ, Wieling W, Goldstein DS, de Bie RM (2011) Prevalence of orthostatic hypotension in Parkinson’s disease: a systematic review and meta-analysis. Parkinsonism Relat Disord 17(10):724–729PubMedCrossRef
15.
Zurück zum Zitat Suzuki M, Urashima M, Oka H, Hashimoto M, Taira K (2007) Cardiac sympathetic denervation in bradykinesia-dominant Parkinson’s disease. NeuroReport 18(17):1867–1870PubMedCrossRef Suzuki M, Urashima M, Oka H, Hashimoto M, Taira K (2007) Cardiac sympathetic denervation in bradykinesia-dominant Parkinson’s disease. NeuroReport 18(17):1867–1870PubMedCrossRef
16.
Zurück zum Zitat Berganzo K, Tijero B, Somme JH, Llorens V, Sanchez-Manso JC, Low D et al (2012) SCOPA-AUT scale in different parkinsonisms and its correlation with (123) I-MIBG cardiac scintigraphy. Parkinsonism Relat Disord 18(1):45–48PubMedCrossRef Berganzo K, Tijero B, Somme JH, Llorens V, Sanchez-Manso JC, Low D et al (2012) SCOPA-AUT scale in different parkinsonisms and its correlation with (123) I-MIBG cardiac scintigraphy. Parkinsonism Relat Disord 18(1):45–48PubMedCrossRef
17.
Zurück zum Zitat Spiegel J, Hellwig D, Farmakis G, Jost WH, Samnick S, Fassbender K et al (2007) Myocardial sympathetic degeneration correlates with clinical phenotype of Parkinson’s disease. Mov Disord Off J Mov Dis Soc 22(7):1004–1008CrossRef Spiegel J, Hellwig D, Farmakis G, Jost WH, Samnick S, Fassbender K et al (2007) Myocardial sympathetic degeneration correlates with clinical phenotype of Parkinson’s disease. Mov Disord Off J Mov Dis Soc 22(7):1004–1008CrossRef
18.
Zurück zum Zitat Deuschl G, Schade-Brittinger C, Krack P et al (2006) A randomized trial of deep-brain stimulation for Parkinson’s disease. N Engl J Med 355:896–908PubMedCrossRef Deuschl G, Schade-Brittinger C, Krack P et al (2006) A randomized trial of deep-brain stimulation for Parkinson’s disease. N Engl J Med 355:896–908PubMedCrossRef
19.
Zurück zum Zitat Goldstein DS, Eldadah BA, Holmes C et al (2005) Neurocirculatory abnormalities in Parkinson disease with orthostatic hypotension: independence from levodopa treatment. Hypertension 46:1333–1339PubMedCrossRef Goldstein DS, Eldadah BA, Holmes C et al (2005) Neurocirculatory abnormalities in Parkinson disease with orthostatic hypotension: independence from levodopa treatment. Hypertension 46:1333–1339PubMedCrossRef
Metadaten
Titel
Nocturnal hypertension and dysautonomia in patients with Parkinson’s disease: are they related?
verfasst von
Koldo Berganzo
Begoña Díez-Arrola
Beatriz Tijero
Johanne Somme
Elena Lezcano
Verónica Llorens
Iratxe Ugarriza
Roberto Ciordia
J. C. Gómez-Esteban
Juan J. Zarranz
Publikationsdatum
01.07.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 7/2013
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-013-6859-5

Weitere Artikel der Ausgabe 7/2013

Journal of Neurology 7/2013 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.